E Fund Management Co., Ltd.
- SEC CIK
- 0001842296
- Latest filing
- Aug 10, 2026
AKRO holding history
Akero Therapeutics, Inc. in every 13F filed by E Fund Management Co., Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AKRO overviewAll 13F holders of AKROFull Q2 2026 holdings
- Shares (Q2 2025)
- 10,395
- Value
- $554.7K
- % of portfolio
- <0.1%
- Quarters held
- 8
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | – | – | – | – | Not filed | Holders |
| Q2 2025 | 10,395 | $554.7K | <0.1% | +3,471+50.1% | Added | Holders |
| Q1 2025 | 6,924 | $280.3K | <0.1% | +6,924 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −13,899−100.0% | Sold out | Holders |
| Q1 2024 | 13,899 | $351.1K | <0.1% | −10,273−42.5% | Reduced | Holders |
| Q4 2023 | 24,172 | $564.4K | <0.1% | +14,744+156.4% | Added | Holders |
| Q3 2023 | 9,428 | $477.0K | <0.1% | +918+10.8% | Added | Holders |
| Q2 2023 | 8,510 | $397.0K | <0.1% | −830−8.9% | Reduced | Holders |
| Q1 2023 | 9,340 | $357.0K | <0.1% | −264−2.7% | Reduced | Holders |
| Q4 2022 | 9,604 | $526.0K | <0.1% | +9,604 | New | Holders |